Skip to main content
. 2020 Mar 11;29(7):1883–1893. doi: 10.1007/s11136-020-02465-x

Table 2.

Sample clinical characteristics of XLH adults aged 26 and over (N= 30)

Mean Range
Age at diagnosis 9 0–47
N
XLH severity (self-reported)
 Mild 7
 Moderate 10
 Severe 9
 Don't know 4
Current treatments
 None 5
 Phosphate 22
 Calcitriol/Vitamin D 24
 Dental procedures 7
 Surgery 6
 Physiotherapy 13
 Analgesicsa 22
 Other treatments 9
Past treatments
 Phosphate 28
 Calcitriol/Vitamin D 29
 Dental procedures 27
 Surgery 22
 Physiotherapy 21
 Growth hormone 2
 Analgesicsa 2
 Other treatments 5
Family history (mother or father)
 Yes 16
 Nob 14
Co-morbidities
 None 17
 Musculoskeletal co-morbidities 7
 Other co-morbidities 8

aNot a prompted response option on the background questionnaire

bReasons included having a parent with no confirmed diagnosis of XLH, being adopted and having a spontaneous gene mutation